(Q45616291)

14 December 2017

title

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine (English)

1 reference

14 December 2017

3

Cosette M Wheeler

1 reference

14 December 2017

13

Kathrin U Jansen

1 reference

14 December 2017

4

Laura A Koutsky

1 reference

14 December 2017

Darron R Brown

1

1 reference

14 December 2017

Kenneth H Fife

2

1 reference

14 December 2017

Lisa M Lupinacci

5

1 reference

14 December 2017

Radha Railkar

6

1 reference

14 December 2017

Gretchen Suhr

7

1 reference

14 December 2017

Eliav Barr

8

1 reference

14 December 2017

Anthony Dicello

9

1 reference

14 December 2017

Weili Li

10

1 reference

14 December 2017

Judith F Smith

11

1 reference

14 December 2017

Amha Tadesse

12

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

14 December 2017

1 reference

14 December 2017

volume

22

1 reference

14 December 2017

issue

21-22

1 reference

14 December 2017

page(s)

2936-2942

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.059

10.1016/J.VACCINE.2003.11.059

7 January 2021

Identifiers

DOI

1 reference

release_gnrqy2yazfhgtfdkuvjgry6dae

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gnrqy2yazfhgtfdkuvjgry6dae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference